Tumor necrosis factor gene polymorphism and septic shock in surgical infection

Critical Care Medicine

Volumn 28, Issue 8, 2000, Pages 2733-2736

  Tang, Gau Jun ^a   Huang, Song Lih ^b   Yien, Huey Wen ^a   Chen, Wei Shone ^a   Chi, Chin Wen ^a   Wu, Chew Wun ^a   Lui, Wing Yiu ^a   Chiu, Jen Hwey ^a   Lee, Tak Yu ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Gene polymorphism; Septic shock; Tumor necrosis factor

Indexed keywords

CYTOKINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALLELE; ARTICLE; BLOOD SAMPLING; CRITICAL ILLNESS; DNA POLYMORPHISM; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SEPTIC SHOCK; SURGICAL INFECTION; SURGICAL PATIENT;

EID: 0033849526     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200008000-00008     Document Type: Article

References (22)

1. Role of tumor necrosis factor-alpha in disease states and inflammation
2. Plasma tumor necrosis factor and mortality in critically ill septic patients
3. Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans
4. Patterns of cytokines, plasma endotoxin, plasminogen activator inhibitor, and acute-phase proteins during the treatment of severe sepsis in humans
5. Perioperatire plasma concentrations of tumor necrosis factor-alpha and interleukin-6 in infected patients
6. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: Relevance to genetic predisposition to systemic lupus erythematosus
7. Endotoxin-stimulated human monocyte secretion of interleukin 1, tumour necrosis factor alpha, and prostaglandin E2 shows stable interindividual differences
8. Control of cachectin (tumor necrosis factor) synthesis: Mechanisms of endotoxin resistance
9. A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis
10. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria
11. Tumor necrosis factor-alpha gene polymorphism in chronic bronchitis
12. Definitions for sepsis and organ failure and guide-lines for the use of innovative therapies in sepsis The ACCP/SCCM. Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine
13. Single base polymorphism in the human tumour necrosis factor alpha (TNF alpha) gene detectable by NcoI restriction of PCR product
14. Effects of a tumor necrosis factor (TNF) promoter base transition on transcriptional activity
15. 308 Tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter
16. Nitric oxide and septic shock
17. L-arginine pathway in the sepsis syndrome
18. NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: Implications for the involvement of nitric oxide
19. NG-methyl-L-arginine, an inhibitor of nitric oxide synthase, reverses interleukin-2-induced hypotension
20. Nitric oxide synthases: Roles, tolls, and controls
21. Hemorrhage activates myocardial NFkappaB and increases TNF-alpha in the heart
22. Does endotoxin tolerance prevent the release of inflammatory monokines (interleukin 1, interleukin 6, or tumor necrosis factor) during sepsis?